CERO
CERO THERAPEUTICS HOLDINGS, INC.
Company Overview
CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.
SectorHealthcare
IndustryBiotechnology
Market Cap$496.2K
Employees8
CEOChristopher Ehrlich
Websitehttps://www.cero.bio
Valuation
Current Price$0.01
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/Aⓘ
EPS (TTM) ?-0.39
Forward EPS Growth ?—
Historical Growth ?92.16%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price
EPS
Revenue
Equity
ProAvailable on the Pro plan
Free Cash Flow
ProAvailable on the Pro plan
Long Term Debt
ProAvailable on the Pro plan
Net Profit
ProAvailable on the Pro plan
Shares Outstanding
ProAvailable on the Pro plan
Last updated: 9/5/2026, 6:04:47 PM